Success story | Assessment of the medical and economical value of pharmaceutical and medical device innovations​

Assessment of the medical and economical value of pharmaceutical and medical device innovations​

CHALLENGES

In the context of: ​

• an acquisition opportunity assessment​
• an internal R&D development (for GO/NO GO decision)​
• the selection of the best therapeutic area for a product in development or the best go-to-market model​

Our clients need to evaluate the potential of an innovation, in terms of medical and economical value. ​

Such assessment requires to understand: the market of the targeted therapeutic area(s), the treatment algorithm, the current and up coming competition, and the specificity of each targeted geographies in terms of market access.​

​

SOLUTIONS

We offer a robust methodology to calculate rather the Top Line or the NPV of innovations: ​

• Market Analysis including epidemiology, market sizing, penetration curve, competition, generics/biosimilars penetration, benefit/risk ratio​
• Assessment of the willingness to use, to define the number of patients to be treated or adoption level such as product positioning in algorithm, competitive positioning, added value, targeted population of patients, willingness to use, geographies specificities in term of pathology management​
• Asssesment of the willingness to pay to define the potential price level in each geography (price level of competition, trends in terms of pricing locally, likely comparators from pricing perspective)​
• Top line or NPV calculation, including development and marketing cost analysis.

CORE KNOW-HOW

• KOLs and Payers interviews​
• Therapeutic areas expertise​
• Product specificities understanding (from small molecules to biologics and medical devices)​

​